139 related articles for article (PubMed ID: 36578014)
1. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.
Papadakos KS; Ekström A; Slipek P; Skourti E; Reid S; Pietras K; Blom AM
J Exp Clin Cancer Res; 2022 Dec; 41(1):363. PubMed ID: 36578014
[TBL] [Abstract][Full Text] [Related]
2. The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.
Englund E; Reitsma B; King BC; Escudero-Esparza A; Owen S; Orimo A; Okroj M; Anagnostaki L; Jiang WG; Jirström K; Blom AM
BMC Cancer; 2015 Oct; 15():737. PubMed ID: 26480818
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
4. Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
Gialeli C; Tuysuz EC; Staaf J; Guleed S; Paciorek V; Mörgelin M; Papadakos KS; Blom AM
J Exp Clin Cancer Res; 2021 Aug; 40(1):258. PubMed ID: 34404439
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer.
Zhong Y; Zheng C; Zhang W; Wu H; Zhang Q; Li D; Ju H; Feng H; Chen Y; Fan Y; Chen W; Wang M; Wang G
Aging (Albany NY); 2024 Apr; 16(7):6417-6444. PubMed ID: 38579174
[TBL] [Abstract][Full Text] [Related]
6. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
[TBL] [Abstract][Full Text] [Related]
7. Partial agonistic effect of cetuximab on epidermal growth factor receptor and Src kinase activation in triple‑negative breast cancer cell lines.
Gurdal H; Tuglu MM; Bostanabad SY; Dalkiliç B
Int J Oncol; 2019 Apr; 54(4):1345-1356. PubMed ID: 30720056
[TBL] [Abstract][Full Text] [Related]
8. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
10. Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.
Holmquist E; Okroj M; Nodin B; Jirström K; Blom AM
FASEB J; 2013 Jun; 27(6):2355-66. PubMed ID: 23482636
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer.
McKnight BN; Kim S; Boerner JL; Viola NT
Breast Cancer Res; 2020 Apr; 22(1):37. PubMed ID: 32295603
[TBL] [Abstract][Full Text] [Related]
12. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
Zhang M; Kim HS; Jin T; Moon WK
J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
[TBL] [Abstract][Full Text] [Related]
14. Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Brand TM; Iida M; Dunn EF; Luthar N; Kostopoulos KT; Corrigan KL; Wleklinski MJ; Yang D; Wisinski KB; Salgia R; Wheeler DL
Mol Cancer Ther; 2014 May; 13(5):1356-68. PubMed ID: 24634415
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution and functional analysis of Sushi domain-containing protein 4.
Tu Z; Cohen M; Bu H; Lin F
Am J Pathol; 2010 May; 176(5):2378-84. PubMed ID: 20348246
[TBL] [Abstract][Full Text] [Related]
16. Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.
Madden JM; Mueller KL; Bollig-Fischer A; Stemmer P; Mattingly RR; Boerner JL
Breast Cancer Res Treat; 2014 Sep; 147(2):283-93. PubMed ID: 25129346
[TBL] [Abstract][Full Text] [Related]
17. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.
Wei Y; Zou Z; Becker N; Anderson M; Sumpter R; Xiao G; Kinch L; Koduru P; Christudass CS; Veltri RW; Grishin NV; Peyton M; Minna J; Bhagat G; Levine B
Cell; 2013 Sep; 154(6):1269-84. PubMed ID: 24034250
[TBL] [Abstract][Full Text] [Related]
18. The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.
Xu W; Song F; Wang B; Li K; Tian M; Yu M; Pan X; Shi B; Liu J; Gu J; Li Z; Jiang H
Cell Physiol Biochem; 2018; 46(1):226-237. PubMed ID: 29587298
[TBL] [Abstract][Full Text] [Related]
19. cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells.
Majorini MT; Manenti G; Mano M; De Cecco L; Conti A; Pinciroli P; Fontanella E; Tagliabue E; Chiodoni C; Colombo MP; Delia D; Lecis D
Cell Death Differ; 2018 Dec; 25(12):2147-2164. PubMed ID: 29674627
[TBL] [Abstract][Full Text] [Related]
20. Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR.
He M; Yan G; Wang Y; Gong R; Lei H; Yu S; He X; Li G; Du W; Ma T; Gao M; Yu M; Liu S; Xu Z; Idiiatullina E; Zagidullin N; Pavlov V; Cai B; Yuan Y; Yang L
J Cell Mol Med; 2021 Jun; 25(11):4962-4973. PubMed ID: 33960631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
